IL159770A0 - Calcium salts with cytotoxic activity - Google Patents

Calcium salts with cytotoxic activity

Info

Publication number
IL159770A0
IL159770A0 IL15977002A IL15977002A IL159770A0 IL 159770 A0 IL159770 A0 IL 159770A0 IL 15977002 A IL15977002 A IL 15977002A IL 15977002 A IL15977002 A IL 15977002A IL 159770 A0 IL159770 A0 IL 159770A0
Authority
IL
Israel
Prior art keywords
calcium salts
medicaments
cytotoxic activity
tumor
administered
Prior art date
Application number
IL15977002A
Other languages
English (en)
Original Assignee
Bilton Consultadoria E Marketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bilton Consultadoria E Marketi filed Critical Bilton Consultadoria E Marketi
Publication of IL159770A0 publication Critical patent/IL159770A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15977002A 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity IL159770A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001495A ITMI20011495A1 (it) 2001-07-12 2001-07-12 Sali di calcio ad attivita' citotossica
PCT/EP2002/007222 WO2003006031A1 (en) 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity

Publications (1)

Publication Number Publication Date
IL159770A0 true IL159770A0 (en) 2004-06-20

Family

ID=11448051

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15977002A IL159770A0 (en) 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity
IL159770A IL159770A (en) 2001-07-12 2004-01-08 Pharmaceutical preparations containing calcium trifluoroacetate with cytotoxic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159770A IL159770A (en) 2001-07-12 2004-01-08 Pharmaceutical preparations containing calcium trifluoroacetate with cytotoxic activity

Country Status (10)

Country Link
US (1) US7423063B2 (de)
EP (1) EP1423131B1 (de)
JP (1) JP4395368B2 (de)
AT (1) ATE345805T1 (de)
CA (1) CA2455710C (de)
DE (1) DE60216292T2 (de)
ES (1) ES2277620T3 (de)
IL (2) IL159770A0 (de)
IT (1) ITMI20011495A1 (de)
WO (1) WO2003006031A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti
ITMI20041279A1 (it) * 2004-06-24 2004-09-24 Pharmaproducts Uk Ltd Uso di calcio trifluoroacetato per la preparazione di medicamenti ad effetto anti-angiogenetico
ITMI20041822A1 (it) 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
EP2796135A1 (de) 2013-04-22 2014-10-29 Polichem S.A. Verwendung von Trifluoressigsäure und Salzen davon zur Behandlung von Hypercholesterinämie
EP2845591A1 (de) 2013-09-04 2015-03-11 Polichem S.A. Verwendung von Trifluoressigsäure als keratolytischer Wirkstoff zur Behandlung hyperkeratotischer Hautläsionen
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CA3087953C (en) 2018-01-12 2025-11-25 Metimedi Pharmaceuticals Co., Ltd. METHODS OF TREATMENT FOR CHRONIC INFLAMMATORY DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636564A (en) * 1984-11-13 1987-01-13 Board Of Trustees Of The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US4880660A (en) * 1987-08-28 1989-11-14 Minnesota Mining And Manufacturing Company Method for priming hard tissue
US5250545A (en) * 1988-02-12 1993-10-05 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitor methods
CN1058390C (zh) * 1993-10-15 2000-11-15 伊莱利利公司 苯并噻吩类化合物的用途
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5639787A (en) * 1995-02-28 1997-06-17 The Center For The Improvement Of Human Functioning Int'l, Inc. Therapeutic method for the treatment of cancer

Also Published As

Publication number Publication date
US7423063B2 (en) 2008-09-09
CA2455710A1 (en) 2003-01-23
JP4395368B2 (ja) 2010-01-06
EP1423131A1 (de) 2004-06-02
ES2277620T3 (es) 2007-07-16
WO2003006031A1 (en) 2003-01-23
DE60216292D1 (de) 2007-01-04
DE60216292T2 (de) 2007-08-30
IL159770A (en) 2009-09-22
US20040180956A1 (en) 2004-09-16
ITMI20011495A0 (it) 2001-07-12
CA2455710C (en) 2012-08-28
ITMI20011495A1 (it) 2003-01-12
EP1423131B1 (de) 2006-11-22
JP2004536120A (ja) 2004-12-02
ATE345805T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
WO2004062604A3 (en) Treatment of cancer with 2-deoxyglucose
IL155781A0 (en) Effective antitumor treatments
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
HK1043313A1 (zh) 用於治疗癌症的多西他赛和rhumab her2
MY113059A (en) Controlled-release dosage forms of azithromycin
BRPI0412426A (pt) uso da zd6474 ou de um sal farmaceuticamente aceitável da mesma e de um agente antitumoral de platina, composição farmacêutica, kit, e método para a produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente
MY164077A (en) Compositions and uses of et743 for treating cancer
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
BR0213906A (pt) Métodos para a produção de um efeito anti-angiogênico e ou redutor da permeabilidade vascular em um animal de sangue quente, e para o tratamento de um câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou um seu sal farmaceuticamente aceitável e um taxano
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
TW200602030A (en) Use of loteprednol etabonate for the treatment of dry eye
CA2534577A1 (en) Method for promoting bone growth
TW200630089A (en) Treatment methods
GB0020504D0 (en) Therapeutic method
IL159770A0 (en) Calcium salts with cytotoxic activity
AU2001236529A1 (en) Combination therapy for cancer
BRPI0412408A (pt) métodos para a produção de um efeito de redução antiangiogênico e/ou de permeabilidade vascular e para o tratamento de um cáncer em um animal de sangue quente tal como um ser humano, composição farmacêutica, kit, e uso de azd2171 ou um sal farmaceuticamente aceitável deste e zd1839 ou um sal farmaceuticamente aceitável deste
IL151627A0 (en) Divided dose therapies with vascular damaging activity
EP1374873B8 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
AU2003229876A1 (en) Tumour associated antigens
IL157408A (en) Use of elemental calcium in the manufacture of a medicament to reduce prostate cancer risk
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA33715A (uk) Спосіб лікування залізодефіцитних анемій у вагітних
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин